# The ECLA PHRI COLCOVID Trial. Effects of Colchicine on Moderate/High-risk Hospitalized COVID-19 Patients.

> **NCT04328480** · PHASE3 · COMPLETED · sponsor: **Estudios Clínicos Latino América** · enrollment: 1279 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** Colchicine
- **OTHER:** Local standard of care

## Key facts

- **NCT ID:** NCT04328480
- **Lead sponsor:** Estudios Clínicos Latino América
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-17
- **Primary completion:** 2021-04-25
- **Final completion:** 2021-04-26
- **Target enrollment:** 1279 (ACTUAL)
- **Last updated:** 2021-04-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04328480

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04328480, "The ECLA PHRI COLCOVID Trial. Effects of Colchicine on Moderate/High-risk Hospitalized COVID-19 Patients.". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04328480. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*